1. Home
  2. DYAI vs CIF Comparison

DYAI vs CIF Comparison

Compare DYAI & CIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • CIF
  • Stock Information
  • Founded
  • DYAI 1979
  • CIF 1988
  • Country
  • DYAI United States
  • CIF United States
  • Employees
  • DYAI N/A
  • CIF N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • CIF Trusts Except Educational Religious and Charitable
  • Sector
  • DYAI Health Care
  • CIF Finance
  • Exchange
  • DYAI Nasdaq
  • CIF Nasdaq
  • Market Cap
  • DYAI 28.3M
  • CIF 30.8M
  • IPO Year
  • DYAI 2004
  • CIF N/A
  • Fundamental
  • Price
  • DYAI $0.98
  • CIF $1.75
  • Analyst Decision
  • DYAI Strong Buy
  • CIF
  • Analyst Count
  • DYAI 1
  • CIF 0
  • Target Price
  • DYAI $6.00
  • CIF N/A
  • AVG Volume (30 Days)
  • DYAI 63.9K
  • CIF 43.9K
  • Earning Date
  • DYAI 08-12-2025
  • CIF 01-01-0001
  • Dividend Yield
  • DYAI N/A
  • CIF 10.11%
  • EPS Growth
  • DYAI N/A
  • CIF N/A
  • EPS
  • DYAI N/A
  • CIF N/A
  • Revenue
  • DYAI $3,554,344.00
  • CIF N/A
  • Revenue This Year
  • DYAI $22.56
  • CIF N/A
  • Revenue Next Year
  • DYAI $30.95
  • CIF N/A
  • P/E Ratio
  • DYAI N/A
  • CIF N/A
  • Revenue Growth
  • DYAI 57.59
  • CIF N/A
  • 52 Week Low
  • DYAI $0.91
  • CIF $1.47
  • 52 Week High
  • DYAI $2.20
  • CIF $1.77
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 53.08
  • CIF 59.42
  • Support Level
  • DYAI $0.91
  • CIF $1.72
  • Resistance Level
  • DYAI $0.99
  • CIF $1.75
  • Average True Range (ATR)
  • DYAI 0.06
  • CIF 0.02
  • MACD
  • DYAI 0.01
  • CIF 0.00
  • Stochastic Oscillator
  • DYAI 59.93
  • CIF 61.26

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About CIF MFS Intermediate High Income Fund

Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.

Share on Social Networks: